Genetic Testing for Pharmacogenomics
Genetic Testing is the backbone of pharmacogenomics, a field that examines how an individual’s genes influence their response to medications. By identifying genetic variants that affect drug metabolism, healthcare providers can prescribe the right drug at the right dose for each patient. This minimizes adverse drug reactions, which are a major cause of hospitalizations, and ensures optimal therapeutic outcomes.
For example, genetic variations in the CYP450 family of enzymes can determine how a person processes antidepressants, blood thinners, or cancer drugs. With pharmacogenomic Genetic Testing, physicians can avoid trial-and-error prescribing and deliver more effective, personalized treatments. As testing becomes more affordable, pharmacogenomics is poised to become a standard component of routine healthcare.